C. Nakar

发表

Hemophilia A with inhibitor: Immune tolerance induction (ITI) in the mirror of time.

A. Shapiro, C. Nakar, 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two US centres

S. Donfield, A. Shapiro, C. Nakar, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004–2008)

D. Cooper, D. Dimichele, C. Nakar, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders

A. Ghafoor, A. Iorio, S. Donfield, 2021, European journal of haematology.

An international registry of patients with plasminogen deficiency (HISTORY)

A. Shapiro, F. Peyvandi, J. Bowen, 2020, Haematologica.

Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency.

P. Laurin, P. Sandset, A. Shapiro, 2018, Blood.

Mycetoma of the renal pelvis caused by Fusarium species.

L. Sirota, Z. Samra, N. Linder, 2001, The Pediatric Infectious Disease Journal.

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label

E. Neufeld, D. Cooper, A. Shapiro, 2016, Pediatric blood & cancer.

Adenovirus Infection in Hospitalized Immunocompetent Children

Z. Samra, Y. Finkelstein, C. Nakar, 2004, Clinical pediatrics.

Eukaryotic Initiation Factor 2α - a Downstream Effector of Mammalian Target of Rapamycin - Modulates DNA Repair and Cancer Response to Treatment

Y. Lawrence, Y. Lerenthal, A. Toren, 2013, PloS one.

Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells.

C. Nakar, J. Yahalom, S. Paglin, 2005, Cancer research.

Congenital Portosystemic Shunts and Liver Hemangiomas in Children: Is There an Association?

Anil Kumar, K. Natarajan, C. Nakar, 2020, Journal of pediatric hematology/oncology.

Mathematical model of thrombin generation and bleeding phenotype in Amish carriers of Factor IX:C deficiency vs. controls.

A. Shapiro, C. Nakar, S. Gupta, 2019, Thrombosis research.

Treatment of ligneous conjunctivitis with plasminogen eyedrops.

A. Shapiro, C. Nakar, P. Mathew, 2022, Ophthalmology.

3G8 and GMA161, Anti FcγRIII Inhibitory Monoclonal Antibodies in the Treatment of Chronic Refractory ITP. (Summary of 2 Pilot Studies).

J. Bussel, C. Nakar, 2009 .

Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two US centres

S. Donfield, A. Shapiro, C. Nakar, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Plasminogen, human‐tvmh for the treatment of children and adults with plasminogen deficiency type 1

C. Nakar, Roberto Crea, Per Morten Sandset, 2023, Haemophilia : the official journal of the World Federation of Hemophilia.

Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1

C. Nakar, Neelam Thukral, A. Shapiro, 2024, Frontiers in pediatrics.